BLIS Technologies Limited logo

Resignation of Chief Marketing Officer

Director Departure22 August 2021BLTConsumer Staples

23 August 2021
Resignation of Chief Marketing Officer

Blis Technologies wishes to advise that Chief Marketing Officer, Julie Curphey, has advised of her

resignation from her role effective 29 October 2021.

Julie joined the company in September 2016 and has had an integral role in several new product and

new market launches during that time.

CEO Brian Watson said: “I’d personally like to thank Julie for her contribution over the last 5 years

and wish her well for her future endeavours. Julie has led a number of significant launch initiatives

for the company, has increased our market presence as a brand and has helped broaden our

revenue opportunities for the future.”

Julie is taking time off and will assess her future direction in the new year.

A search for Julie’s replacement will commence shortly.


Ends


For further information, please contact:


Brian Watson

CEO

+64 27 705 9133



About Blis Technologies Ltd


Delivering proven health benefits through evidence-based, advanced probiotics

Blis Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut.

Combining innovation with evidence-based research and the highest quality production controls enables

the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath),

immune support, teeth and gum health and skin health. BLIS® products are sold throughout New Zealand

and in Australia, Asia, Europe and the USA. More information about Blis Technologies Ltd can be found at

www.blis.co.nz.


Website: www.unconditionalskin.com

Instagram: @unconditionalskin #BLISQ24 #USC

Facebook: @unconditionalskin

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.